Plain-English translation of NCT06356012 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing , a cream that boosts your body's immune system, to see if it can treat high-grade cervical lesions caused by HPV before they turn into cancer. Researchers want to understand how your immune system responds to this medication, and whether it works as well as standard surgical treatment. They'll also study the bacteria in your cervix and vagina to learn more about how the treatment works.
High-grade cervical lesions are warning signs that could become cervical cancer if untreated. While surgery is the standard treatment, this medication offers a non-invasive option that works by waking up your body's natural defenses. This trial will help doctors understand which patients benefit most from this approach and how to predict who will respond well.
You likely qualify if…
You likely don't qualify if…
If you're in the treatment group, you'll apply the immune-boosting cream to your cervix twice a week for 8 weeks, then have a surgical procedure to remove any remaining lesion about 60 days later. Researchers will collect blood samples and cervical fluid at multiple visits to study your immune response and the bacteria in your cervix. You'll also be compared to a group receiving only surgery and a healthy control group to help doctors understand how well the medication works.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
Brazil